Signaling Pathway
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 52021 | Ganetespib(STA-9090) | 888216-25-9 | 98% |  |
| Ganetespib blocked the ability of HSP90 to bind to biotinylated geldanamycin and disr | ||||
| 51803 | Semaxanib (SU5416) | 204005-46-9 | 98% | -cas-204005-46-9.png) |
| Semaxanib (SU5416) is a potent and selectiveVEGFR(Flk-1/KDR) inhibitor withIC50of 1.2 | ||||
| 122919 | Tenapanor | 1234423-95-0 | 98% |  |
| Tenapanoris an inhibitor of the sodium-proton exchanger NHE3. Thisantiporter protein | ||||
| 16122810 | Elacestrant dihydrochloride | 1349723-93-8 | ≧98.0% |  |
| Elacestrant dihydrochloride, also known as RAD1901, is an orally available, selective | ||||
| 185216 | Iberdomide | 1323403-33-3 | >98% |  |
| Iberdomide, also known as CC-220, is potentially for the treatment of systemic lupus | ||||
| 512193 | ITI-214(phosphate) | 1642303-38-5 | 98% Min. |  |
| ITI-214 is a potent and selective phosphodiesterase 1 (PDE1) inhibitor. As the clinic | ||||
| 204504 | Zegocractin ( CM-4620 ) | 1713240-67-5 | ≧98.0% | _1713240-67-5.png) |
| Zegocractin (CM-4620, Auxora(TM)) is a small-molecule inhibitor of the calcium releas | ||||
| 2091906 | BAY-2416964 | 2242464-44-2 | 98% Min. |  |
| BAY-2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist | ||||
| 21248 | Giredestrant | 1953133-47-5 | ≧98.0% |  |
| Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally ava | ||||
| 20367 | Piflufolastat | 1423758-00-2 | ≧96% |  |
| Piflufolastat, also known as DCFPYL is a PSMA-targeted PET imaging agent for prostate | ||||
| 20264 | ALC-0315 | 2036272-55-4 | 98% Min. |  |
| ALC-0315 is a synthetic cationic lipid (or ionizable lipid). It is a colorless oily m | ||||
| 20274 | Dimethyl carbate | 39589-98-5 | 98% Min. |  |
| Dimethyl carbate is an insect repellent. It can be prepared by the Diels–Alder reac | ||||